Alexander Mathes Selected Research

paxilline

10/2019	Impact of Ca2+-Sensitive Potassium Channels in Levosimendan-Induced Postconditioning.
10/2018	Milrinone-Induced Postconditioning Requires Activation of Mitochondrial Ca2+-sensitive Potassium (mBKCa) Channels.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alexander Mathes Research Topics

Disease

10	Infarction (Infarctions) 04/2020 - 04/2017
7	Ischemia 04/2020 - 01/2018
5	Reperfusion Injury 01/2020 - 04/2017
3	Hemorrhage 08/2019 - 05/2008
3	Hemorrhagic Shock 08/2019 - 05/2008
2	Shock 08/2019 - 05/2008
2	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2018 - 01/2018
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020
1	Myocardial Reperfusion Injury 10/2019
1	Endotoxemia 08/2019
1	Heart Failure 03/2019
1	Acute Kidney Injury (Acute Renal Failure) 01/2009
1	Thrombocytopenia (Thrombopenia) 01/2009
1	Critical Illness (Critically Ill) 01/2009

Drug/Important Bio-Agent (IBA)

5	triphenyltetrazoliumIBA 04/2020 - 01/2018
4	ramelteon (Rozerem)FDA Link 04/2020 - 01/2018
3	Dexmedetomidine FDA Link 01/2020 - 04/2017
3	Krebs-Henseleit solutionIBA 01/2020 - 01/2018
2	NS 1619IBA 04/2020 - 04/2017
2	paxillineIBA 10/2019 - 10/2018
2	Simendan (Levosimendan)IBA 10/2019 - 03/2019
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 08/2019 - 01/2009
2	N(1)-methyl-2-lysergic acid diethylamide (MIL)IBA 04/2019 - 03/2019
2	Milrinone (Primacor)FDA LinkGeneric 03/2019 - 10/2018
2	Melatonin Receptors (Melatonin Receptor)IBA 01/2018 - 01/2018
1	MK 2206IBA 04/2020
1	KT 5823IBA 04/2020
1	MT2 Melatonin ReceptorIBA 01/2020
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2020
1	4-phenyl-2-propionamidotetralineIBA 01/2020
1	PotassiumIBA 10/2019
1	(R)- N- (benzimidazol- 2- yl)- 1,2,3,4- tetrahydro- 1- naphthylamineIBA 10/2019
1	ChloridesIBA 10/2019
1	LipopolysaccharidesIBA 08/2019
1	salicylhydroxamic acid (SHAM)IBA 08/2019
1	Anesthetics (Anesthetic Agents)IBA 03/2019
1	omecamtiv mecarbilIBA 03/2019
1	MelatoninIBA 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	Potassium Channels (Potassium Channel)IBA 01/2018
1	luzindoleIBA 01/2018
1	Hemoglobins (Hemoglobin)IBA 08/2009
1	Endothelin-1 (Endothelin 1)IBA 08/2009
1	Heparin (Liquaemin)FDA LinkGeneric 01/2009
1	AntithrombinsIBA 01/2009
1	NitrogenIBA 01/2009
1	Urea (Carbamide)FDA LinkGeneric 01/2009
1	N 30IBA 01/2009
1	argatroban (MPQA)FDA Link 01/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2008
1	Ringer's SolutionIBA 05/2008
1	NADP (NADPH)IBA 05/2008
1	Heme Oxygenase-1IBA 05/2008
1	Hemin (Panhematin)FDA Link 05/2008
1	Carbon MonoxideIBA 05/2008
1	Interleukin-10 (Interleukin 10)IBA 05/2008
1	CytokinesIBA 05/2008

Therapy/Procedure

2	Therapeutics 03/2019 - 08/2009
2	Resuscitation 08/2009 - 05/2008
1	Continuous Renal Replacement Therapy 01/2009